1. Home
  2. ADV vs CADL Comparison

ADV vs CADL Comparison

Compare ADV & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADV
  • CADL
  • Stock Information
  • Founded
  • ADV 1987
  • CADL 1999
  • Country
  • ADV United States
  • CADL United States
  • Employees
  • ADV N/A
  • CADL N/A
  • Industry
  • ADV Business Services
  • CADL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADV Consumer Discretionary
  • CADL Health Care
  • Exchange
  • ADV Nasdaq
  • CADL Nasdaq
  • Market Cap
  • ADV 417.2M
  • CADL 339.8M
  • IPO Year
  • ADV N/A
  • CADL 2021
  • Fundamental
  • Price
  • ADV $1.17
  • CADL $4.67
  • Analyst Decision
  • ADV Strong Buy
  • CADL Strong Buy
  • Analyst Count
  • ADV 1
  • CADL 7
  • Target Price
  • ADV $2.50
  • CADL $19.43
  • AVG Volume (30 Days)
  • ADV 526.8K
  • CADL 650.0K
  • Earning Date
  • ADV 11-06-2025
  • CADL 11-13-2025
  • Dividend Yield
  • ADV N/A
  • CADL N/A
  • EPS Growth
  • ADV N/A
  • CADL N/A
  • EPS
  • ADV N/A
  • CADL N/A
  • Revenue
  • ADV $3,502,796,000.00
  • CADL N/A
  • Revenue This Year
  • ADV N/A
  • CADL N/A
  • Revenue Next Year
  • ADV $0.67
  • CADL N/A
  • P/E Ratio
  • ADV N/A
  • CADL N/A
  • Revenue Growth
  • ADV N/A
  • CADL N/A
  • 52 Week Low
  • ADV $1.04
  • CADL $3.79
  • 52 Week High
  • ADV $3.76
  • CADL $14.60
  • Technical
  • Relative Strength Index (RSI)
  • ADV 35.12
  • CADL 34.79
  • Support Level
  • ADV $1.12
  • CADL $4.46
  • Resistance Level
  • ADV $1.39
  • CADL $5.32
  • Average True Range (ATR)
  • ADV 0.10
  • CADL 0.27
  • MACD
  • ADV 0.00
  • CADL -0.07
  • Stochastic Oscillator
  • ADV 10.00
  • CADL 13.43

About ADV Advantage Solutions Inc.

Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: